FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Novelties in the treatment of osteoarthritis

Novine u lečenju osteoartritisa

Thumbnail
2016
2773.pdf (361.4Kb)
Authors
Stepanović-Petrović, Radica
Tomić, Maja
Article (Published version)
Metadata
Show full item record
Abstract
Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's physical functionality. Therapy consists of: nonpharmacological measures, pharmacotherapy and surgery. Although nonpharmacological approach represents a basis of OA treatment, pharmacotherapy is an important adjunct. Medications that are used in this disease can be administered orally, topically or intra-articularly. In OA treatment the following medications are used: analgesics, glucosamine- and chondroitin-based preparations, glucocorticoids and hyaluronic acid (intra-articular administration) and other medications. Nonopioid analgesics represent a corner stone in OA pharmacotherapy. Treatment initiation with paracetamol (acetaminophen) and/or topical nonsteroidal anti-inflammatory drug (NSAID) is recommended. Afterwards, in a case of complete or partial treatment failure, oral traditional NSAID (tNSAID) or selective COX-2 inhibitor should be used, or opioids as a substitute or an adjunct.... Glucosamine- and chondroitin-based preparations are not recommended for OA treatment. Intra-articular use of glucocorticoid (triamcinolon) can lead to short lasting removal of pain and inflammation, while intra-articular use of hyaluronic acid is not recommended. Surgical treatment is important for heavy joint damage and in the case of failure of other treatment modalities.

Cilj lečenja osteoartritisa (OA) je ublažiti bol i smanjiti gubitak fizičke funkcionalnosti pacijenta. Terapija se sastoji od: nefarmakoloških mera, farmakoterapije i hirurgije. Mada nefarmakološki pristup predstavlja osnovu lečenja OA, farmakoterapija je važan dodatak lečenju. Lekovi koji se primenjuju u ovoj bolesti mogu se davati per os, topikalno ili intraartikularno. U lečenju OA koriste se sledeći lekovi: analgetici, preparati na bazi glukozamina i hondroitina, glukokortikoidi i hijaluronska kiselina (intraartikularna primena) i ostali lekovi. Kamen temeljac u farmakoterapiji OA čine neopioidni analgetici. Preporučuje se otpočinjanje terapije paracetamolom i/ili topikalnim nesteroidnim antiinflamatornim lekom (NSAIL), nakon čega u slučaju potpunog ili delimičnog neuspeha treba primeniti oralne tradicionalne NSAIL/selektivne inhibitore ciklooksigenaze 2, ili opioide kao zamenu ili dodatak terapiji. Preparati na bazi glukozamina i hondroitina se ne preporučuju za lečenje OA. Intraa...rtikularna primena glukokortikoida (triamcinolon) može da dovede do kratkotrajnog otklanjanja bola i inflamacije, dok se intraartikularna primena hijaluronske kiseline ne preporučuje. Hirurško lečenje je važno kod teških oštećenja zglobova u OA i neuspeha ostalih oblika lečenja.

Keywords:
non-opioid analgesics / tramadol / glucosamine / chondroitin / neopioidni analgetici / tramadol / glukozamin / hondroitin
Source:
Arhiv za farmaciju, 2016, 66, 6, 257-266
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

DOI: 10.5937/arhfarm1606257S

ISSN: 0004-1963

Scopus: 2-s2.0-85019070103
[ Google Scholar ]
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/2775
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Stepanović-Petrović, Radica
AU  - Tomić, Maja
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2775
AB  - Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's physical functionality. Therapy consists of: nonpharmacological measures, pharmacotherapy and surgery. Although nonpharmacological approach represents a basis of OA treatment, pharmacotherapy is an important adjunct. Medications that are used in this disease can be administered orally, topically or intra-articularly. In OA treatment the following medications are used: analgesics, glucosamine- and chondroitin-based preparations, glucocorticoids and hyaluronic acid (intra-articular administration) and other medications. Nonopioid analgesics represent a corner stone in OA pharmacotherapy. Treatment initiation with paracetamol (acetaminophen) and/or topical nonsteroidal anti-inflammatory drug (NSAID) is recommended. Afterwards, in a case of complete or partial treatment failure, oral traditional NSAID (tNSAID) or selective COX-2 inhibitor should be used, or opioids as a substitute or an adjunct. Glucosamine- and chondroitin-based preparations are not recommended for OA treatment. Intra-articular use of glucocorticoid (triamcinolon) can lead to short lasting removal of pain and inflammation, while intra-articular use of hyaluronic acid is not recommended. Surgical treatment is important for heavy joint damage and in the case of failure of other treatment modalities.
AB  - Cilj lečenja osteoartritisa (OA) je ublažiti bol i smanjiti gubitak fizičke funkcionalnosti pacijenta. Terapija se sastoji od: nefarmakoloških mera, farmakoterapije i hirurgije. Mada nefarmakološki pristup predstavlja osnovu lečenja OA, farmakoterapija je važan dodatak lečenju. Lekovi koji se primenjuju u ovoj bolesti mogu se davati per os, topikalno ili intraartikularno. U lečenju OA koriste se sledeći lekovi: analgetici, preparati na bazi glukozamina i hondroitina, glukokortikoidi i hijaluronska kiselina (intraartikularna primena) i ostali lekovi. Kamen temeljac u farmakoterapiji OA čine neopioidni analgetici. Preporučuje se otpočinjanje terapije paracetamolom i/ili topikalnim nesteroidnim antiinflamatornim lekom (NSAIL), nakon čega u slučaju potpunog ili delimičnog neuspeha treba primeniti oralne tradicionalne NSAIL/selektivne inhibitore ciklooksigenaze 2, ili opioide kao zamenu ili dodatak terapiji. Preparati na bazi glukozamina i hondroitina se ne preporučuju za lečenje OA. Intraartikularna primena glukokortikoida (triamcinolon) može da dovede do kratkotrajnog otklanjanja bola i inflamacije, dok se intraartikularna primena hijaluronske kiseline ne preporučuje. Hirurško lečenje je važno kod teških oštećenja zglobova u OA i neuspeha ostalih oblika lečenja.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Novelties in the treatment of osteoarthritis
T1  - Novine u lečenju osteoartritisa
VL  - 66
IS  - 6
SP  - 257
EP  - 266
DO  - 10.5937/arhfarm1606257S
ER  - 
@article{
author = "Stepanović-Petrović, Radica and Tomić, Maja",
year = "2016",
abstract = "Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's physical functionality. Therapy consists of: nonpharmacological measures, pharmacotherapy and surgery. Although nonpharmacological approach represents a basis of OA treatment, pharmacotherapy is an important adjunct. Medications that are used in this disease can be administered orally, topically or intra-articularly. In OA treatment the following medications are used: analgesics, glucosamine- and chondroitin-based preparations, glucocorticoids and hyaluronic acid (intra-articular administration) and other medications. Nonopioid analgesics represent a corner stone in OA pharmacotherapy. Treatment initiation with paracetamol (acetaminophen) and/or topical nonsteroidal anti-inflammatory drug (NSAID) is recommended. Afterwards, in a case of complete or partial treatment failure, oral traditional NSAID (tNSAID) or selective COX-2 inhibitor should be used, or opioids as a substitute or an adjunct. Glucosamine- and chondroitin-based preparations are not recommended for OA treatment. Intra-articular use of glucocorticoid (triamcinolon) can lead to short lasting removal of pain and inflammation, while intra-articular use of hyaluronic acid is not recommended. Surgical treatment is important for heavy joint damage and in the case of failure of other treatment modalities., Cilj lečenja osteoartritisa (OA) je ublažiti bol i smanjiti gubitak fizičke funkcionalnosti pacijenta. Terapija se sastoji od: nefarmakoloških mera, farmakoterapije i hirurgije. Mada nefarmakološki pristup predstavlja osnovu lečenja OA, farmakoterapija je važan dodatak lečenju. Lekovi koji se primenjuju u ovoj bolesti mogu se davati per os, topikalno ili intraartikularno. U lečenju OA koriste se sledeći lekovi: analgetici, preparati na bazi glukozamina i hondroitina, glukokortikoidi i hijaluronska kiselina (intraartikularna primena) i ostali lekovi. Kamen temeljac u farmakoterapiji OA čine neopioidni analgetici. Preporučuje se otpočinjanje terapije paracetamolom i/ili topikalnim nesteroidnim antiinflamatornim lekom (NSAIL), nakon čega u slučaju potpunog ili delimičnog neuspeha treba primeniti oralne tradicionalne NSAIL/selektivne inhibitore ciklooksigenaze 2, ili opioide kao zamenu ili dodatak terapiji. Preparati na bazi glukozamina i hondroitina se ne preporučuju za lečenje OA. Intraartikularna primena glukokortikoida (triamcinolon) može da dovede do kratkotrajnog otklanjanja bola i inflamacije, dok se intraartikularna primena hijaluronske kiseline ne preporučuje. Hirurško lečenje je važno kod teških oštećenja zglobova u OA i neuspeha ostalih oblika lečenja.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Novelties in the treatment of osteoarthritis, Novine u lečenju osteoartritisa",
volume = "66",
number = "6",
pages = "257-266",
doi = "10.5937/arhfarm1606257S"
}
Stepanović-Petrović, R.,& Tomić, M.. (2016). Novelties in the treatment of osteoarthritis. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 66(6), 257-266.
https://doi.org/10.5937/arhfarm1606257S
Stepanović-Petrović R, Tomić M. Novelties in the treatment of osteoarthritis. in Arhiv za farmaciju. 2016;66(6):257-266.
doi:10.5937/arhfarm1606257S .
Stepanović-Petrović, Radica, Tomić, Maja, "Novelties in the treatment of osteoarthritis" in Arhiv za farmaciju, 66, no. 6 (2016):257-266,
https://doi.org/10.5937/arhfarm1606257S . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB